Morgan Stanley’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13
| Closed | -$279 | – | 8095 |
|
|
2024
Q1 | $279 | Buy |
+13
| New | +$279 | ﹤0.01% | 7283 |
|
|
2023
Q1 | – | Sell |
-77
| Closed | -$384 | – | 7885 |
|
|
2022
Q4 | $384 | Sell |
77
-788
| -91% | -$3.93K | ﹤0.01% | 7587 |
|
|
2022
Q3 | $5K | Sell |
865
-100
| -10% | -$578 | ﹤0.01% | 7275 |
|
|
2022
Q2 | $8K | Buy |
965
+239
| +33% | +$1.98K | ﹤0.01% | 7297 |
|
|
2022
Q1 | $11K | Sell |
726
-14,652
| -95% | -$222K | ﹤0.01% | 7388 |
|
|
2021
Q4 | $738K | Buy |
15,378
+15,204
| +8,738% | +$730K | ﹤0.01% | 5293 |
|
|
2021
Q3 | $26K | Sell |
174
-517
| -75% | -$77.3K | ﹤0.01% | 6999 |
|
|
2021
Q2 | $81K | Buy |
691
+643
| +1,340% | +$75.4K | ﹤0.01% | 6443 |
|
|
2021
Q1 | $5K | Buy |
+48
| New | +$5K | ﹤0.01% | 7126 |
|